The study of coenzyme Q10 supplementation on blood pressure, inflammation factors& Adiponectin in hypertensive patients
- Conditions
- hypertension.High blood pressure
- Registration Number
- IRCT201103086002N1
- Lead Sponsor
- Shahid Sadughi University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
willingness to cooperate in the project and complete a written informed consent, diagnosis of hypertensive patients based on diagnostic criteria and clinical examination by a physician, No pregnant or breastfeeding women, the absence of any autoimmune disorders, cardio - vascular, or renal diseases, lack of nutritional supplements during the past six months
Exclusion criteria: diabetes mellitus type 1 or type 2, the history of disease such as myocardial infarction, cardiac dysfunction, cardiac arrhythmia, angina and kidney disease, autoimmune diseases like MS, rheumatism, etc, BMI> 40, factors causing secondary hypertension, supplementation of vitamin, mineral or other nutritional supplements, Alcohol or drug use, Incidence of severe side effects, non-compliance with study protocol
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IL6. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Hypertension. Timepoint: At At baseline, weeks after the sixth and twelfth week baseline. Method of measurement: Measured by standard mercury blood pressure measuring device sitting.;IL2. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Hs-CRP. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;TNF-a. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.;Adiponectin. Timepoint: At baseline, after the sixth week and twelfth week baseline. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method